Clearview Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-200
| Closed | -$1.47K | – | 257 |
|
|
2023
Q2 | $1.47K | Hold |
200
| – | – | ﹤0.01% | 558 |
|
|
2023
Q1 | $2.07K | Hold |
200
| – | – | ﹤0.01% | 517 |
|
|
2022
Q4 | $2.36K | Hold |
200
| – | – | ﹤0.01% | 466 |
|
|
2022
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 423 |
|
|
2022
Q2 | $6K | Hold |
200
| – | – | ﹤0.01% | 412 |
|
|
2022
Q1 | $8K | Hold |
200
| – | – | 0.01% | 410 |
|
|
2021
Q4 | $9K | Hold |
200
| – | – | 0.01% | 432 |
|
|
2021
Q3 | $10K | Hold |
200
| – | – | 0.01% | 416 |
|
|
2021
Q2 | $13K | Hold |
200
| – | – | 0.01% | 383 |
|
|
2021
Q1 | $19K | Hold |
200
| – | – | 0.01% | 338 |
|
|
2020
Q4 | $18K | Buy |
+200
| New | +$18K | 0.01% | 313 |
|